Olivia Martinez
Family · Fremont, CANPI 1629490362
Payments from drug & device makers
Across 550 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$2K
- AbbVie$2K
- Johnson & Johnson$773
- UCB, Inc.$707
- Pfizer$681
- Arcutis Biotherapeutics, Inc.$509
- plus $4K from 21 others
What the payments were for
- Consulting fees$4804%
- Food & beverage$9,89990%
- Education$5975%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 129 | $2,048 |
| AbbVie(2 entities) | 89 | $1,925 |
| Johnson & Johnson | 38 | $773 |
| UCB, Inc. | 54 | $707 |
| Pfizer | 34 | $681 |
| Arcutis Biotherapeutics, Inc. | 13 | $509 |
| Lilly USA, LLC | 25 | $462 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $459 |
| Amgen | 21 | $452 |
| Regeneron Healthcare Solutions, Inc. | 14 | $433 |
| Novartis | 14 | $382 |
| Sun Pharmaceutical Industries Inc. | 15 | $376 |
| E.r. Squibb & Sons, L.L.C. | 12 | $363 |
| Sanofi | 10 | $304 |
| Incyte Corporation | 14 | $271 |
| Galderma Laboratories, L.p. | 8 | $267 |
| Dermavant Sciences, Inc. | 13 | $252 |
| Novo Nordisk | 3 | $61 |
| Journey Medical Corporation | 3 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $44 |
| Organon | 6 | $42 |
| Organogenesis Inc. | 1 | $25 |
| Botanix SB Inc | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $21 |
| Strata Skin Sciences, Inc. | 1 | $19 |
| Janssen Scientific Affairs, LLC | 1 | $13 |
| Biofrontera Inc. | 3 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,976 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 17 | $81,581 |
| OpzeluraRuxolitinib Phosphate | 19 | $35,456 |
| Calcipotriene | 63 | $13,858 |
| Tacrolimus | 72 | $9,676 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 149 | $9,107 |
| Clobetasol Propionate | 74 | $7,673 |
| Fluocinonide | 114 | $5,669 |
| Imiquimod | 12 | $3,718 |
| Metronidazole | 40 | $2,955 |
| Triamcinolone Acetonide | 252 | $2,904 |
| Ketoconazole | 136 | $2,759 |
| Clindamycin Phosphate | 47 | $1,692 |
| Selenium Sulfide | 95 | $1,549 |
| Betamethasone Dipropionate | 30 | $1,081 |
| Hydrocortisone | 161 | $698 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $452 | $81,58117 claims |
| Incyte CorporationOpzelura | $271 | $35,45619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Fremont
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.